BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6190378)

  • 1. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
    Seeger W; Wolf H; Graubert E; Moser U; Neuhof H; Roka L
    Adv Exp Med Biol; 1983; 156():553-67. PubMed ID: 6190378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
    Freise J; Wittenberg H; Magerstedt P
    Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J; Magerstedt P; Schmid K
    Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative influence of the Ca-ionophore A 23187, bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism.
    Seeger W; Neuhof H; Graubert E; Wolf H; Roka L
    Adv Exp Med Biol; 1983; 156():533-51. PubMed ID: 6407283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs.
    Seeger W; Wolf H; Stähler G; Neuhof H; Róka L
    Prostaglandins; 1982 Feb; 23(2):157-73. PubMed ID: 6805041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
    Hesse B; Lankisch PG; Kunze H
    Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the thromboxane antagonist BM 13.177 on the arachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs.
    Seeger W; Ernst C; Walmrath D; Neuhof H; Roka L
    Thromb Res; 1985 Dec; 40(6):793-805. PubMed ID: 3937288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR; Büchler M; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs.
    Seeger W; Menger M; Walmrath D; Becker G; Grimminger F; Neuhof H
    Am Rev Respir Dis; 1987 Oct; 136(4):964-72. PubMed ID: 2821856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of an aprotinin-sensitive protease in protein kinase Calpha-mediated activation of cytosolic phospholipase A2 by calcium ionophore (A23187) in pulmonary endothelium.
    Chakraborti S; Michael JR; Chakraborti T
    Cell Signal; 2004 Jun; 16(6):751-62. PubMed ID: 15093616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of A23187, exogenous phospholipase A2 and exogenous arachidonic acid on pulmonary vascular resistance in isolated rabbit lung.
    Littner MR; Kazmi GM; Lott FD
    J Pharmacol Exp Ther; 1987 Sep; 242(3):974-80. PubMed ID: 3116202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiproteases (aprotinin and gabexate-mesilate) on the postischemic vascular response of the kidney.
    Pflüger H; Maier M; Binder BR
    Urol Int; 1983; 38(3):150-7. PubMed ID: 6191420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
    Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
    Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin decreases pulmonary vascular permeability under baseline conditions and after administration of arachidonic acid in rabbit lungs.
    Seeger W; Walmrath D; Heimburger N; Neuhof H
    Thromb Res; 1986 Oct; 44(2):135-46. PubMed ID: 3097869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular (thrombocytes, granulocytes) effects of proteinase inhibitors--gabexylate, gabexate mesilate (FOY) and aprotinin.
    Redl H; Schlag G; Paul E; Schiesser A
    Resuscitation; 1986 Sep; 14(1-2):81-90. PubMed ID: 2431445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous arachidonic acid metabolism by calcium ionophore A23187-stimulated lamb lungs: effect of hypoxia.
    Ibe BO; Isenberg WB; Raj JU
    Am J Respir Cell Mol Biol; 1991 Apr; 4(4):379-85. PubMed ID: 1901720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
    Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
    Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase of pulmonary vascular resistance and permeability due to the metabolism of free arachidonic acid (author's transl)].
    Seeger W; Wolf H; Stähler G; Neuhof H; Róka L
    Klin Wochenschr; 1981 May; 59(9):459-61. PubMed ID: 7278087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.